VRDN Stock Analysis: Buy, Sell, or Hold?
VRDN - Viridian Therapeutics, Inc. Common Stock
$17.43
0.39 (2.29%)
▲
5d:
+2.53%
30d:
+17.14%
90d:
-39.37%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Smart Money Accumulation
VRDN is down 3.9% this week, but smart money is accumulating calls. Top strike: $17 2026-07-17 with 1,917 OI. Call ratio: 96% View Scanner →
Strength: 6.5/10
Get Alerted When VRDN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called VRDN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VRDN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VRDN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VRDN is currently trading at $17.43, which is considered extended relative to its 30-day fair value range of $13.62 to $16.59.
Technical Outlook: Technically, VRDN is in a strong uptrend. Immediate support is located at $13.24, while resistance sits at $20.00.
Market Sentiment: VRDN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $34.56 (+98.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VRDN is in a strong uptrend. Immediate support is located at $13.24, while resistance sits at $20.00.
Market Sentiment: VRDN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $34.56 (+98.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$13.62 -
$16.59
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding VRDN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 98.3% below Wall St target ($34.56)
Trading Range Analysis
30-Day Trading Range
$13.62 -
$16.59
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$13.24
Resistance Level
$20.00
Current Trend
Strong Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.05
Wall Street Target
$34.56
(+98.3%)
Revenue Growth (YoY)
95.8%
Share & Embed Analysis
Last updated: May 15, 2026 7:44 AM ET
Data refreshes hourly during market hours. Next update: 8:44 AM
Data refreshes hourly during market hours. Next update: 8:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VRDN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jennifer Tousignant
SELL
2272 shares
2025-12-31
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 54 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$23 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 58 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$208 | 49 HOLD |
Advanced VRDN Option Strategies
Professional options setups generated by AI based on today's VRDN price and gamma walls.
